1. Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial;Abarca;EClinicalMedicine,2020
2. Palivizumab‐resistant human respiratory syncytial virus infection in infancy;Adams;Clin. Infect. Dis.,2010
3. Taxonomy of the order Mononegavirales: update 2016;Afonso;Arch. Virol.,2016
4. Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials;Ahani;Nat. Commun.,2023
5. A phase 1 randomized, double-blind, placebo-controlled trial to assess the safety, Tolerability, and pharmacokinetics of a respiratory syncytial virus neutralizing monoclonal antibody MK-1654 in healthy adults;Aliprantis;Clin Pharmacol Drug Dev,2021